Ciprofloxacin (CIPROFLOXACIN HYDROCHLORIDE)
Ciprofloxacin (CIPROFLOXACIN HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Ciprofloxacin; Generic name: CIPROFLOXACIN HYDROCHLORIDE; Manufacturer: American Health Packaging.
| Brand name | Ciprofloxacin |
|---|---|
| Generic name | CIPROFLOXACIN HYDROCHLORIDE |
| Manufacturer | American Health Packaging |
| Used for | 1 INDICATIONS AND USAGE Ciprofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections (1.1) Bone and Joint Infections (1.2) Complicated Intra-Abdominal Infections (1.3) Infectious Diarrhea (1.4) Typhoid Fever (Enteric Fever) (1.5) Uncomplicated Cervical and Urethral Gonorrhea (1.6) Inhalational Anthrax post-exposure in adult and pediatric patients (1.7) Plague in adult and pediatric patients (1.8) Chronic Bacterial Prostatitis (1.9) Lower Respiratory Tract Infections (1.10) Acute Exacerbation of Chroni |
| Dosage | 2 DOSAGE AND ADMINISTRATION Ciprofloxacin tablets should be administered orally as described in the appropriate Dosage Guidelines tables. Adult Dosage Guidelines Infection Dose Frequency Duration Skin and Skin Structure 500 to 750 mg every 12 hours 7 to 14 days Bone and Joint 500 to 750 mg every 12 hours 4 to 8 weeks Complicated Intra- Abdominal 500 mg every 12 hours 7 to 14 days Infectious Diarrhea 500 mg every 12 hours 5 to 7 days Typhoid Fever 500 mg every 12 hours 10 days Uncomplicated Gonor |
| Warnings | WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYASTHENIA GRAVIS Fluoroquinolones, including ciprofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together [see Warnings and Precautions (5.1) ] including: Tendinitis and tendon rupture [see Warnings and Precautions (5.2) ] Peripheral neuropathy [see Warnings and Precautions (5.3 |
| Active ingredient(s) | CIPROFLOXACIN HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fac4466-fbe5-49d2-96e3-e3ac2739bd5b |